George Lundberg, MD Editor in Chief at Cancer Commons
-
February 18, 2022
Olaparib Shows Promise for Castrate-Resistant Prostate Cancer Bookmark
George Lundberg, MDThis Business Wire press release announces results from a clinical trial indicating that adding the drug olaparib (brand name Lynparza) to treatment for castrate-resistant prostate cancer enhanced disease-free progression, regardless of biomarker status.
.
-
February 18, 2022
Realistic Expectations After Prostate Cancer Treatment Bookmark
George Lundberg, MDThis story from The ASCO Post discusses how doctors can help ensure that patients have realistic expectations about outcomes after prostate cancer treatment.
.
-
February 18, 2022
Chemotherapy: Before Surgery Vs. After Surgery Bookmark
George Lundberg, MDAccording to this article from the Cochrane Database of Systematic Reviews, chemotherapy administered before surgery may be beneficial for people with advanced ovarian cancer.
.
-
February 18, 2022
This New Ovarian Cancer Treatment Could Improve Survival Rates Bookmark
George Lundberg, MDRecently approved by the U.S. Food and Drug Administration (FDA), the drug Cytalux is given to ovarian cancer patients to allow surgeons to recognize cancer cells more clearly, promoting more complete surgical removal of tumors. Learn more in this story from The Philadelphia Inquirer.
.
-
February 3, 2022
World Cancer Day 2022 Bookmark
George Lundberg, MDIn 2000, the Union for International Cancer Control established World Cancer Day, to be held every year on February 4. This year’s theme is “Close the Care Gap,” which is “all about understanding and recognizing the inequities in cancer care around the globe.” Learn more here.
.
-
February 3, 2022
Kidney Cancer Clinical Trials at UCSD Bookmark
George Lundberg, MDEnrolling in a clinical trial can be great way to access cutting-edge treatments. Here, the University of California, San Diego, keeps a running list of clinical trials offered there that are currently enrolling people with kidney cancer.
.
-
February 3, 2022
Kidney Cancer Clinical Trials at UCSF Bookmark
George Lundberg, MDEnrolling in a clinical trial can be great way to access cutting-edge treatments. Here, the University of California, San Francisco, keeps a running list of clinical trials offered there that are currently enrolling people with kidney cancer.
.
-
February 3, 2022
Bladder Cancer Clinical Trials at UCSD Bookmark
George Lundberg, MDEnrolling in a clinical trial can be great way to access cutting-edge treatments. Here, the University of California, San Diego, keeps a running list of clinical trials offered there that are currently enrolling people with bladder cancer.
.
-
February 3, 2022
Transitional Cell Carcinoma Clinical Trials at UCSF Bookmark
George Lundberg, MDEnrolling in a clinical trial can be great way to access cutting-edge treatments. Here, the University of California, San Francisco, keeps a running list of clinical trials offered there that are currently enrolling people with transitional cell carcinoma, the most common form of bladder cancer.
.
-
January 31, 2022
NCCN Guidelines for Patients: Peripheral T-Cell Lymphoma Bookmark
George Lundberg, MDThe nonprofit National Comprehensive Cancer Network (NCCN) publishes guidelines for patients to learn more about their diagnosis and their treatment options. Here is their 2022 update for peripheral T-cell lymphoma (PTCL).
.